Mancini M, Cappello A, Pecorari R, Lena A M, Montanaro M, Fania L, Ricci F, Di Lella G, Piro M C, Abeni D, Dellambra E, Mauriello A, Melino G, Candi E
Istituto Dermopatico Dell'Immacolata-IRCCS, via dei Monti di Creta 104, 00167, Rome, Italy.
Department of Experimental Medicine, University of Rome "Tor Vergata", via Montpellier 1, 00133, Rome, Italy.
Discov Oncol. 2021 May 3;12(1):14. doi: 10.1007/s12672-021-00409-6.
While non-melanoma skin cancers (NMSCs) are the most common tumours in humans, only the sub-type cutaneous squamous cell carcinoma (cSCC), might become metastatic with high lethality. We have recently identified a regulatory pathway involving the lncRNA transcript uc.291 in controlling the expression of epidermal differentiation complex genes via the interaction with ACTL6A, a component of the chromatin remodelling complex SWI/SNF. Since transcribed ultra-conserved regions (T-UCRs) are expressed in normal tissues and are deregulated in tumorigenesis, here we hypothesize a potential role for dysregulation of this axis in cSCC, accounting for the de-differentiation process observed in aggressive poorly differentiated cutaneous carcinomas. We therefore analysed their expression patterns in human tumour biopsies at mRNA and protein levels. The results suggest that by altering chromatin accessibility of the epidermal differentiation complex genes, down-regulation of uc.291 and BRG1 expression contribute to the de-differentiation process seen in keratinocyte malignancy. This provides future direction for the identification of clinical biomarkers in cutaneous SCC. Analysis of publicly available data sets indicates that the above may also be a general feature for SCCs of different origins.
虽然非黑色素瘤皮肤癌(NMSCs)是人类最常见的肿瘤,但只有皮肤鳞状细胞癌(cSCC)这一亚型可能发生转移并具有高致死性。我们最近发现了一条涉及长链非编码RNA转录本uc.291的调控途径,它通过与染色质重塑复合物SWI/SNF的一个组分ACTL6A相互作用来控制表皮分化复合基因的表达。由于转录的超保守区域(T-UCRs)在正常组织中表达且在肿瘤发生过程中失调,在此我们推测该轴的失调在cSCC中具有潜在作用,这可以解释在侵袭性低分化皮肤癌中观察到的去分化过程。因此,我们在mRNA和蛋白质水平分析了它们在人类肿瘤活检组织中的表达模式。结果表明,通过改变表皮分化复合基因的染色质可及性,uc.291和BRG1表达的下调促成了角质形成细胞恶性肿瘤中所见的去分化过程。这为皮肤鳞状细胞癌临床生物标志物的鉴定提供了未来方向。对公开可用数据集的分析表明,上述情况可能也是不同来源鳞状细胞癌的一个普遍特征。